ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Nanoparticles for oral delivery: targeted therapy for inflammatory bowel disease

Li, De-feng; Yang, Mei-feng; Xu, Hao-ming; Zhu, Min-zheng; Zhang, Yuan; Tian, Cheng-mei; Nie, Yu-qiang; Wang, Jian-yao*; Liang, Yu-jie*; Yao, Jun*; Wang, Li-sheng*惠州学院; 1
Journal of Materials Chemistry B2022-8-10DOI: 10.1039/d2tb01190e
30被引15阅读
引用收藏
分享

摘要

As a group of chronic and idiopathic gastrointestinal (GI) disorders, inflammatory bowel disease (IBD) is characterized by recurrent intestinal mucosal inflammation. Oral administration is critical for the treatment of IBD. Unfortunately, it is difficult to target the bowel located in the GI tract due to multiple physical barriers. The unique physicochemical properties of nanoparticle-based drug delivery systems (DDSs) and their enhanced permeability and retention effects in the inflamed bowel, render nanomedicines to be used to implement precise drug delivery at diseased sites in IBD therapy. In this review, we described the pathophysiological features of IBD, and designed strategies to exploit these features for intestinal targeting. In addition, we introduced the types of currently developed nano-targeted carriers, including synthetic nanoparticle-based and emerging naturally derived nanoparticles (e.g., extracellular vesicles and plant-derived nanoparticles). Moreover, recent developments in targeted oral nanoparticles for IBD therapy were also highlighted. Finally, we presented challenges associated with nanotechnology and potential directions for future IBD treatment.

学科与关键词

关键词
SOLID LIPID NANOPARTICLESREACTIVE OXYGEN METABOLITESPH-SENSITIVE NANOPARTICLESLOADED PLGA NANOPARTICLESDRUG-DELIVERYEXPERIMENTAL COLITISULCERATIVE-COLITISPOLYMERIC NANOPARTICLESEXTRACELLULAR VESICLESINTESTINAL BARRIER
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Journal of Materials Chemistry B
发表日期
2022-08-10
卷期
第 10 卷, 第 31 期
页码
5853-5872
DOI
10.1039/d2tb01190e
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
Natural Science Foundation of Guangdong Province [2018A0303100024]; Technical Research and Development Project of Shenzhen [JCYJ2015 0403101028164, JCYC20170307100911479, JCYJ2019 0807145617113, JCYJ20210324113802006]; Shenzhen Fund for Guangdong Provincial High Level Clinical Key Specialties [SZGSP013]; Shenzhen Key Medical Discipline Construction Fund [SZXK042]; National Natural Science Foundation of China [81800489]

作者

  • L

    Li, De-feng (第一作者)

    1 · 2

  • Y

    Yang, Mei-feng

查看全部 11 位作者收起作者
  • X

    Xu, Hao-ming

    1

  • Z

    Zhu, Min-zheng

    1

  • Z

    Zhang, Yuan

    huizhou inst

  • T

    Tian, Cheng-mei

    1 · 2

  • N

    Nie, Yu-qiang

    1

  • W

    Wang, Jian-yao (通讯)

    shenzhen childrens hosp

  • L

    Liang, Yu-jie (通讯)

    shenzhen kangning hosp

  • Y

    Yao, Jun (通讯)

    1 · 2

  • W

    Wang, Li-sheng (通讯)

    1 · 2

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417